Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

@article{Ross2013GeneticVI,
  title={Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy},
  author={Colin J. D. Ross and Hagit Katzov-Eckert and Marie-Pierre Dub{\'e} and Beth Brooks and Shahrad Rod Rassekh and Amina Barhdadi and Yassamin Feroz-Zada and Henk Visscher and Andrew M. K. Brown and Michael John Rieder and P. Clint Rogers and Michael S. Phillips and Bruce Carleton and Michael R. Hayden},
  journal={Nature Genetics},
  year={2013},
  volume={45},
  pages={578-578}
}

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 68 extracted citations

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2017
View 8 Excerpts
Highly Influenced

ADME Processes in Pharmaceutical Sciences

Springer International Publishing • 2018

Similar Papers

Loading similar papers…